BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gutzmer R, Wiegand S, Kölbl O, Wermker K, Heppt M, Berking C. Actinic Keratosis and Cutaneous Squamous Cell Carcinoma. Dtsch Arztebl Int 2019;116:616-26. [PMID: 32048593 DOI: 10.3238/arztebl.2019.0616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wright Q, Gonzalez Cruz JL, Wells JW, Leggatt GR. PD-1 and beyond to Activate T Cells in Cutaneous Squamous Cell Cancers: The Case for 4-1BB and VISTA Antibodies in Combination Therapy. Cancers (Basel) 2021;13:3310. [PMID: 34282763 DOI: 10.3390/cancers13133310] [Reference Citation Analysis]
2 Reinhold U, Bai-Habelski J, Abeck D, Denfeld R, Dominicus R, Fischer T, Radny P. [Potassium hydroxide 5 % solution in actinic keratosis : A novel therapeutic approach in the lesion-directed treatment]. Hautarzt 2021. [PMID: 34387709 DOI: 10.1007/s00105-021-04888-0] [Reference Citation Analysis]
3 Wessely A, Steeb T, Heppt F, Hornung A, Kaufmann MD, Koch EAT, Toussaint F, Erdmann M, Berking C, Heppt MV. A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic Keratosis. Curr Oncol 2021;28:950-60. [PMID: 33617511 DOI: 10.3390/curroncol28010093] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Burda B, Schultz ES. Das kutane Plattenepithelkarzinom – ein Update. Aktuelle Dermatologie 2022;48:155-61. [DOI: 10.1055/a-1666-3585] [Reference Citation Analysis]